210 related articles for article (PubMed ID: 28418010)
21. Effect of NUDT15 on incidence of neutropenia in children with acute lymphoblastic leukemia.
Buaboonnam J; Sripatanatadasakul P; Treesucon A; Glomglao W; Siraprapapat P; Narkbunnam N; Vathana N; Takpradit C; Phuakpet K; Pongtanakul B; Tongsai S; Sinlapamongkolkul P; Sanpakit K
Pediatr Int; 2019 Aug; 61(8):754-758. PubMed ID: 31166660
[TBL] [Abstract][Full Text] [Related]
22. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia.
Moriyama T; Nishii R; Lin TN; Kihira K; Toyoda H; Jacob N; Kato M; Koh K; Inaba H; Manabe A; Schmiegelow K; Yang JJ; Hori H
Pharmacogenet Genomics; 2017 Jun; 27(6):236-239. PubMed ID: 28445187
[TBL] [Abstract][Full Text] [Related]
23. Allele-specific polymerase chain reaction can determine the diplotype of NUDT15 variants in patients with childhood acute lymphoblastic Leukemia.
Yu CH; Chang YH; Wang DS; Jou ST; Lin CY; Lin KH; Lu MY; Wu KH; Cheng CN; Chang HH; Chou SW; Su MY; Ni YL; Xu PY; Lin DT; Lin SW; Chen HY; Yang YL
Sci Rep; 2023 Jan; 13(1):490. PubMed ID: 36627439
[TBL] [Abstract][Full Text] [Related]
24. NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia.
Yoshida M; Nakabayashi K; Yang W; Sato-Otsubo A; Tsujimoto SI; Ogata-Kawata H; Kawai T; Ishiwata K; Sakamoto M; Okamura K; Yoshida K; Shirai R; Osumi T; Moriyama T; Nishii R; Takahashi H; Kiyotani C; Shioda Y; Terashima K; Ishimaru S; Yuza Y; Takagi M; Arakawa Y; Kinoshita A; Hino M; Imamura T; Hasegawa D; Nakazawa Y; Okuya M; Kakuda H; Takasugi N; Inoue A; Ohki K; Yoshioka T; Ito S; Tomizawa D; Koh K; Matsumoto K; Sanada M; Kiyokawa N; Ohara A; Ogawa S; Manabe A; Niwa A; Hata K; Yang JJ; Kato M
Blood Adv; 2021 Dec; 5(23):5420-5428. PubMed ID: 34662904
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenetics of 6-mercaptopurine in a black Zimbabwean cohort treated for acute lymphoblastic leukaemia.
Chikondowa P; Munkombwe D; Chikwambi Z; Kuona P; Masimirembwa C
Pharmacogenomics; 2023 Jun; 24(8):449-457. PubMed ID: 37248698
[TBL] [Abstract][Full Text] [Related]
26. Genotyping NUDT15 can predict the dose reduction of 6-MP for children with acute lymphoblastic leukemia especially at a preschool age.
Suzuki H; Fukushima H; Suzuki R; Hosaka S; Yamaki Y; Kobayashi C; Sakai A; Imagawa K; Iwabuchi A; Yoshimi A; Nakao T; Kato K; Tsuchida M; Kiyokawa N; Koike K; Noguchi E; Fukushima T; Sumazaki R
J Hum Genet; 2016 Sep; 61(9):797-801. PubMed ID: 27193222
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic accuracy of NUDT15 gene variants for thiopurine-induced leukopenia: a systematic review and meta-analysis.
Cargnin S; Genazzani AA; Canonico PL; Terrazzino S
Pharmacol Res; 2018 Sep; 135():102-111. PubMed ID: 30048756
[TBL] [Abstract][Full Text] [Related]
28. Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations.
Maillard M; Nishii R; Yang W; Hoshitsuki K; Chepyala D; Lee SHR; Nguyen JQ; Relling MV; Crews KR; Leggas M; Singh M; Suang JLY; Yeoh AEJ; Jeha S; Inaba H; Pui CH; Karol SE; Trehan A; Bhatia P; Antillon Klussmann FG; Bhojwani D; Haidar CE; Yang JJ
J Natl Cancer Inst; 2024 May; 116(5):702-710. PubMed ID: 38230823
[TBL] [Abstract][Full Text] [Related]
29. Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia.
Tanaka Y; Manabe A; Fukushima H; Suzuki R; Nakadate H; Kondoh K; Nakamura K; Koh K; Fukushima T; Tsuchida M; Koike K; Kiyokawa N; Noguchi E; Sumazaki R; Komiyama T
Pharmacogenomics J; 2015 Aug; 15(4):380-4. PubMed ID: 25403995
[TBL] [Abstract][Full Text] [Related]
30. The influence of
Nguyen ML; Hoang AV; Duong BT; Phung NTN
HGG Adv; 2023 Apr; 4(2):100183. PubMed ID: 36873097
[TBL] [Abstract][Full Text] [Related]
31. Influence of
Kojima Y; Hirotsu Y; Omata W; Sugimori M; Takaoka S; Ashizawa H; Nakagomi K; Yoshimura D; Hosoda K; Suzuki Y; Mochizuki H; Omata M
World J Gastroenterol; 2018 Jan; 24(4):511-518. PubMed ID: 29398872
[TBL] [Abstract][Full Text] [Related]
32. Mercaptopurine induced myelosuppression in a child with a
Gupta N; Magatha LS; Jayaraman D; Scott JX; Antony SB; Koshy T
J Oncol Pharm Pract; 2023 Jun; 29(4):999-1001. PubMed ID: 36341754
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetic evaluation of 6-mercaptopurine-mediated toxicity in pediatric acute lymphoblastic leukemia patients from a South Indian population.
Ramalingam R; Kaur H; Scott JX; Sneha LM; Arun Kumar GP; Srinivasan A; Paul SF
Pharmacogenomics; 2021 May; 22(7):401-411. PubMed ID: 33876659
[No Abstract] [Full Text] [Related]
34. Pharmacogenetic determinants of thiopurines in an Indian cohort.
Naushad SM; Janaki Ramaiah M; Kutala VK; Hussain T; Alrokayan SA
Pharmacol Rep; 2021 Feb; 73(1):278-287. PubMed ID: 32935219
[TBL] [Abstract][Full Text] [Related]
35. [Association between polymorphism of NUDT15 gene and hepatotoxicity induced by 6-MP in children with acute lymphoblastic leukemia].
Wang X; Wang W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Dec; 38(12):1258-1261. PubMed ID: 34839520
[TBL] [Abstract][Full Text] [Related]
36. NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine.
Khaeso K; Komvilaisak P; Chainansamit SO; Nakkam N; Suwannaying K; Kuwatjanakul P; Hikino K; Dornsena A; Kanjanawart S; Laoaroon N; Vannaprasaht S; Taketani T; Tassaneeyakul W
Drug Metab Pharmacokinet; 2022 Apr; 43():100436. PubMed ID: 35016134
[TBL] [Abstract][Full Text] [Related]
37. Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in Chinese ALL children and possible association with mercaptopurine related toxicity.
Ma X; Zheng J; Jin M; Li W; Gao C; Zhang D; Chen Y; Li X; Xie J
Int J Clin Exp Pathol; 2014; 7(7):4552-6. PubMed ID: 25120852
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia.
Khera S; Trehan A; Bhatia P; Singh M; Bansal D; Varma N
Cancer Chemother Pharmacol; 2019 Feb; 83(2):341-348. PubMed ID: 30474703
[TBL] [Abstract][Full Text] [Related]
39. Low NUDT15 expression levels due to biallelic NUDT15 variants and 6-mercaptopurine intolerance.
Yoshida M; Brown SA; Moriyama T; Nishii R; Tsujimoto SI; Yamada Y; Yoshida K; Shirai R; Osumi T; Utano T; Fukano R; Kudo K; Sakaguchi K; Arakawa Y; Koh K; Sekiguchi M; Sekimizu M; Miyamura T; Ishida H; Inukai T; Tomizawa D; Kiyokawa N; Kato M; Yang JJ
Br J Haematol; 2022 Oct; 199(2):270-276. PubMed ID: 35905175
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia.
Moriyama T; Yang W; Smith C; Pui CH; Evans WE; Relling MV; Bhatia S; Yang JJ
Pharmacogenet Genomics; 2022 Feb; 32(2):60-66. PubMed ID: 34412101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
